Otonomy

Otonomy

Biotechnology, 4796 Executive Dr, San Diego, California, 92121, United States, 51-200 Employees

otonomy.com

  • facebook
  • LinkedIn

phone no Phone Number: 61********

Who is OTONOMY

Otonomy is a biopharmaceutical company dedicated to the development of innovative therapeutics for diseases and disorders of the ear. The company pioneered the application of drug deliver...

Read More

map
  • 4796 Executive Dr, San Diego, California, 92121, United States Headquarters: 4796 Executive Dr, San Diego, California, 92121, United States
  • 2008 Date Founded: 2008
  • 51-200 Employees: 51-200
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2836 | NAICS Code: 325414 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from OTONOMY

Otonomy Org Chart and Mapping

Employees

Anne Elliott

Director, Clinical Operations and Drug Safety

Alan Foster

Chief Scientific Officer

Steve Stuckey

Otology Sales Specialist/ Hospital Account Manager

Bob Savel

Chief Technical Officer

James Vestal

Senior Animal Care Technician

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Otonomy

Answer: Otonomy's headquarters are located at 4796 Executive Dr, San Diego, California, 92121, United States

Answer: Otonomy's phone number is 61********

Answer: Otonomy's official website is https://otonomy.com

Answer: Otonomy's revenue is $1 Million to $5 Million

Answer: Otonomy's SIC: 2836

Answer: Otonomy's NAICS: 325414

Answer: Otonomy has 51-200 employees

Answer: Otonomy is in Biotechnology

Answer: Otonomy contact info: Phone number: 61******** Website: https://otonomy.com

Answer: Otonomy is a biopharmaceutical company dedicated to the development of innovative therapeutics for diseases and disorders of the ear. The company pioneered the application of drug delivery technology to the ear in order to develop products that achieve sustained drug exposure from a single local administration. This approach is covered by a broad patent estate and is being utilized to develop a pipeline of products addressing important unmet medical needs including Menieres disease, hearing loss, and tinnitus.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access